Publication | Closed Access

Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications

Metabolic SyndromeCardiovascular DiseaseMedicineHeme DegradationPhysiologyMyeloperoxidase LevelsLipid PeroxidationVascular BiologyParaoxonase-1 Arylesterase ActivityRedox BiologyDyslipidemiaReactive Oxygen SpecieMetabolismPharmacologyAtherosclerosisOverweight PatientsOxidative StressHealth Sciences